Unlock Berlin's trial potential

Together we’ll bring medical breakthroughs to patients

Overall vision & goal

This project connects patients, doctors, and researchers to help more people access new treatments, faster.

The goal is to make it easier and faster for people in Berlin to find and join research studies that offer new treatment options for various health conditions.

These studies give patients access to promising and innovative therapies while helping doctors and researchers improve care for the future.

Everyone can make a difference — not just patients, but also families, caregivers, and friends, by learning about new possibilities and supporting their loved ones.

Together, we can help bring alternative treatments to people sooner, make research more accessible to everyone, and strengthen Berlin as a city of medical innovation and hope.

What Sponsors and Partners say

Ninon Armbrust

Head of Sites
FutureMeds

Ute Bertelsmann

Geschäftsführerin 
kfgn | Site Operations & Services

Michael Sandner

Studienteilnehmer

News

LIVE from Berlin – On November 3rd, we hosted our Better Together Berlin kick-off event, showcasing the first week’s performance, and hosting sponsors, CROs, sites and even patients to drive actionable change for trial participation in Berlin.

Thank you to everyone involved in this project, we’re looking forward to bringing trials to the forefront of all Berliners, and know knows which Capital will be next as part of the ‘Better Together’ series.

Gallery

Boots on the Ground

Direct Community Engagement in Berlin.

To bridge the gap between clinical research and Berlin’s diverse population, our team has been taking the ‘Better Together’ initiative directly to the heart of the city. Over the past few months, we have moved beyond digital outreach to engage in real-life conversations where they matter most. From local pharmacies and medical practices to community centers and cultural hubs, we are meeting people in their daily environments to build trust and increase the visibility of clinical trials.

Sponsor benefits

Faster enrollment: 
Reduction of “time to first patient in” and faster overall recruitment timelines, critical for hitting your enrollment milestones.
Higher quality data:
More informed and motivated patients lead to lower dropout rates and better protocol adherence, improving data quality.
Cost efficiency: 
Reduced delays and faster recruitment mean substantial cost savings over the lifecycle of a trial.
Visibility & impact: 
Public awareness of innovation, patient engagement, and commitment to improving research accessibility in Berlin.

Site benefits

Recruitment support: 
Tools, campaigns, and services (e.g. local awareness initiatives) to drive more, and better-prepared patients to the sites.
Visibility: 
Promotion of Berlin’s sites as research centers of excellence, attracting both patients and sponsors.
Capacity building: 
Training, operational support, and materials to help sites optimize enrollment processes and patient management.
Community integration: 
Helping sites become more visible, and trusted parts of their local communities through public education and outreach.

Patient benefits

Awareness: City-wide visibility (digital, print, community events) that educates the public of local clinical trials and why participation matters.
Access: Easier and faster access to clinical trials through a centralized platform (ClinLife^® Berlin), engagement at healthcare touchpoints, and local events.
Trust & engagement: Clear and transparent communication that emphasizes patient rights, safety, and the value of participation.
Support: Patient-friendly materials, multilingual resources (German, Turkish, Polish, Spanish, French, Arabic, and English) to guide participants before and during trials.

Affiliate benefits

Local activation:
A structured, ready-to-use framework for local teams to engage with Berlin’s healthcare system, patients, and investigators.
Operational efficiency: 
Faster study starts, quicker recruitment, and fewer protocol deviations, thanks to a more educated and motivated patient population.
Regulatory alignment:
Support for German national clinical research goals, helping affiliates meet corporate KPIs and country-level targets, such as the Medical Research Act (MRA).
Reputation boost:
Participation in a socially impactful initiative that strengthens the affiliate’s image among HCPs, patients, and policymakers.

Interested in what we’re doing across Berlin?

Discover the full scope of our city-wide campaign, click to get the full story.

What is OncoCONNECT and why is it important for this project?

As part of Better Together, we are integrating our specialized innovative solution OncoCONNECT, enabling direct and effective oncology HCP engagement and significantly improving patient conversion.

Place your Onco trial where the decisions are taken (e.g. in the tumor board)

Onco-optimized flow with individual pathway interviews early on.
Study companion service for patients to provide easier access to studies.
Onco-trained specialists engage treating HCPs.
Local KOL network and hyper-targeted campaigns to cancer centers.

Why OncoCONNECT matters?

Oncology trials make up for +50% of the portfolio of clinical trials worldwide, and in Berlin.
Oncology studies often face unique recruitment and retention challenges due to complexity, urgency, and eligibility constraints.
OncoCONNECT offers tailored outreach, patient education, HCP engagement to better support patients getting enrolled in a clinical trial.
Including OncoCONNECT within Better Together allows us to address high-impact therapeutic areas while keeping the initiative scalable and inclusive.

Why should all key stakeholders get involved?

Want to learn more about each perspective? Click below for all the details.